WC
Woodstock Corp Portfolio holdings
AUM
$1.09B
This Quarter Return
+14.39%
1 Year Return
+20.65%
3 Year Return
+97.37%
5 Year Return
+175.97%
10 Year Return
+415.12%
AUM
$558M
AUM Growth
+$558M
(+12%)
Cap. Flow
-$5.67M
Cap. Flow
% of AUM
-1.02%
Top 10 Holdings %
Top 10 Hldgs %
27.9%
Holding
168
New
6
Increased
33
Reduced
75
Closed
4
Top Buys
| 1 |
NVIDIA
NVDA
|
$917K |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$778K |
| 3 |
Schlumberger
SLB
|
$668K |
| 4 |
Viking Therapeutics
VKTX
|
$544K |
| 5 |
Varonis Systems
VRNS
|
$291K |
Top Sells
| 1 |
Ubiquiti
UI
|
$1.02M |
| 2 |
Ecolab
ECL
|
$953K |
| 3 |
Emergent Biosolutions
EBS
|
$615K |
| 4 |
Microsoft
MSFT
|
$589K |
| 5 |
Boeing
BA
|
$584K |
Sector Composition
| 1 | Healthcare | 25.27% |
| 2 | Technology | 20.71% |
| 3 | Industrials | 9.61% |
| 4 | Consumer Staples | 8.52% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Amgen
AMGN
$152B
| $1.49M | 0.27% |
7,845
-300
| -4% | -$57K |
|
77
Flowserve
FLS
$6.96B
| $1.46M | 0.26% |
32,300
| – | – |
|
78
AT&T
T
$207B
| $1.45M | 0.26% |
46,320
-2,200
| -5% | -$69K |
|
79
Dominion Energy
D
$50.3B
| $1.39M | 0.25% |
18,082
-365
| -2% | -$28K |
|
|
RDS.A
80
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.33M | 0.24% |
21,295
-50
| -0.2% | -$3.13K |
|
81
Neurocrine Biosciences
NBIX
$13.8B
| $1.31M | 0.23% |
14,880
| – | – |
|
82
GE Aerospace
GE
$294B
| $1.31M | 0.23% |
131,166
-3,175
| -2% | -$31.7K |
|
|
AYX
83
DELISTED
Alteryx, Inc.
AYX
| $1.28M | 0.23% |
15,269
| – | – |
|
|
84
Boeing
BA
$176B
| $1.27M | 0.23% |
3,334
-1,532
| -31% | -$584K |
|
85
SPDR S&P MidCap 400 ETF Trust
MDY
$23.5B
| $1.16M | 0.21% |
3,367
-100
| -3% | -$34.5K |
|
86
General Dynamics
GD
$86.8B
| $1.11M | 0.2% |
6,550
| – | – |
|
87
IBM
IBM
$225B
| $1.09M | 0.2% |
7,752
-2,590
| -25% | -$366K |
|
88
Hain Celestial
HAIN
$163M
| $1.04M | 0.19% |
44,855
-250
| -0.6% | -$5.78K |
|
89
American Express
AXP
$226B
| $1.03M | 0.18% |
9,442
-110
| -1% | -$12K |
|
90
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $1.02M | 0.18% |
24,079
-173
| -0.7% | -$7.35K |
|
|
BLUE
91
DELISTED
bluebird bio
BLUE
| $1.01M | 0.18% |
6,408
+137
| +2% | +$21.6K |
|
92
FibroGen
FGEN
$48.1M
| $1.01M | 0.18% |
18,490
| – | – |
|
93
McCormick & Company Non-Voting
MKC
$18.5B
| $957K | 0.17% |
6,350
-775
| -11% | -$117K |
|
94
Southern Company
SO
$101B
| $951K | 0.17% |
18,401
-600
| -3% | -$31K |
|
95
S&P Global
SPGI
$165B
| $941K | 0.17% |
4,470
| – | – |
|
96
Iron Mountain
IRM
$26.4B
| $917K | 0.16% |
25,857
+1,209
| +5% | +$42.9K |
|
97
Aldeyra Therapeutics
ALDX
$352M
| $893K | 0.16% |
98,841
+8,756
| +10% | +$79.1K |
|
|
GWPH
98
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $886K | 0.16% |
5,256
| – | – |
|
99
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $866K | 0.16% |
21,199
+250
| +1% | +$10.2K |
|
100
Vertex Pharmaceuticals
VRTX
$101B
| $794K | 0.14% |
4,319
| – | – |
|